Study linking HRT with dementia risk ‘unhelpful’ Experts point out that no causal relationship between menopausal hormone therapy and dementia has been established.
‘A very challenging space’: Opioid deprescribing guide released Work for guidelines was led by researchers at the University of Sydney and includes 11 recommendations with general practice in mind.
In Practice: AGPT Academic Post applications now open Successful applicants will receive hands-on experience in teaching and research, while enhancing their skills in academia.
GPs encouraged to prepare for opioid dependence changes All opioid dependence treatment medicines will be listed on the PBS from next month, in news welcomed by the RACGP.
Does multimorbidity impact chronic disease treatment? New international research has looked into a range of chronic diseases and their potential impact on effectiveness of common medications.
‘Historic’ funding changes for opioid dependency treatment Addiction GPs say the changes will help to reduce barriers when it comes to prescribing and access – and in the process reduce stigma.
Our adult vaccination program needs a shot in the arm Australia has enviable childhood vaccination rates, but the increasingly vulnerable adult population is being left behind, writes Dr Sarah Chu.
Opioid treatment receives $377m funding increase The measure, included in this week’s Federal Budget, will ‘save lives’, according to the RACGP President.
Shingrix to replace Zostavax on the National Immunisation Program The news has been welcomed by the Immunisation Coalition, but there are also concerns about eligibility restrictions.
Budget reveals $5.7 billion general practice investment Funding will go towards the creation of a new level E consultation item, rebate indexation, telehealth, the bulk billing incentive, and multidisciplinary care.